Spatial sequencing is viewing a specific region within a tissue, then sequencing all transcripts found in that region. Spatial sequencing allows for the ability to map variation in gene expression across a tissue or region of interest. Q2 Solutions utilizes leading technologies such as the Nanostring GeoMx® Digital Spatial Profiler (DSP). We can meet your spatial needs with our extensive services spanning the clinical research continuum combined with our global laboratory network and expert support team.
Located within our global headquarters in Durham, NC, USA, Q2 Solutions Innovations Laboratories offers the operational alignment necessary for seamless workflows and scientific collaborations due in part to being located in the same geographical location. This team specializes in exploratory and translational biomarker discovery with a focus on new technologies. This alignment of expertise and laboratories is both a unique offering to the field and improves the likelihood of successful project outcomes for large and small endeavors. With scientific thought leaders from anatomic pathology, flow cytometry, genomics, vaccine development, and large molecule bioanalytical services under one roof, Q2 Solutions is well poised to engineer solutions and create novel service offerings for sponsors in support of our mission to turn patients’ hope into the help they need. Learn More.
Single cell RNA sequencing (scRNA-seq) uncovers tissue heterogeneity by providing gene expression measurements in individual cells within a tissue. A current limitation of scRNA-seq is the...
Next generation sequencing (NGS)-based comprehensive genomic profiling has emerged as a powerful tool for the large-scale detection of genomic changes. TruSight Oncology 500 (TSO500) Assay employs a...
Download this presentation to learn more about a new protocol using Chromium Gene Expression Flex to successfully and reliably conduct single cell RNA sequencing with FFPE tumor biopsy tissues. ...